Regencell Bioscience Holdings Ltd (RGC)
↓ Download CSVKey ratios (FY2025)
-73.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$3.77M | -$4.74M | -$6.27M | -$7.62M | -$1.38M | -$812.4K | -$391.0K | — |
| Net Income | -$3.58M | -$4.30M | -$5.87M | -$7.45M | -$1.35M | -$812.4K | -$391.0K | — |
| EPS (Diluted) | $-0.72 | $-0.87 | $-1.19 | $-0.58 | $-0.13 | $-0.08 | — | — |
| Total Assets | $5.76M | $8.44M | $12.62M | $18.02M | $340.1K | $514.0K | — | — |
| Total Liabilities | $895.3K | $219.5K | $632.3K | $938.0K | $4.34M | $3.16M | — | — |
| Shareholders' Equity | $4.86M | $8.22M | $12.03M | $17.07M | -$4.00M | -$2.65M | -$1.84M | -$1.45M |
| Cash & Equivalents | — | — | — | $6.42M | $59.4K | $387.0K | $243.3K | $153.3K |
| Operating Cash Flow | -$3.11M | -$4.00M | -$4.96M | -$5.27M | -$767.3K | -$726.6K | -$391.0K | — |
| Capital Expenditures | $152.7K | $5.4K | $27.4K | $780.9K | — | $117.8K | — | — |
| Shares Outstanding | 494.49M | 494.49M | 13.01M | 13.01M | 10.00M | 10.00M | — | — |